Additionally, previous studies demonstrated that PBRM1 loss shows a nonimmunogenic tumor phenotype associated with ICIs [17], and CD8 T cell infiltration of immunofluorescence in CheckMate025 was not associated with response to PD-1 blockade [4]. Here, PBRM1 is linked to neoplasm.